Cencora, Inc. Common Stock (COR)
Industrials › Wholesale-Drugs, Proprietaries & Druggists' Sundries
Price History
Feb 9, 2026 — May 20, 2026Investment Snapshot
- Trading 212% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 106.1% — good return on equity
- Revenue growing at 9% annually
Cencora, Inc. Common Stock (COR) is a Industrials company operating in Wholesale-Drugs, Proprietaries & Druggists' Sundries, listed on the NYSE , with a market capitalisation of $51.8 billion . Key value metrics: P/E ratio 14.4, P/B ratio 15.24, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Cencora, Inc. Common Stock — Fundamental Analysis Summary
Cencora, Inc. Common Stock (COR) is currently trading 212% above its Graham Number of $85.34, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 14.4x.
On financial health, COR shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and strong return on equity of 106.1% (sector average: 4.9%), and high leverage with a debt-to-equity ratio of 3.71.
StockPik's composite Value Score for COR is 55/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
COR reports a thin gross margin of 3.9% (sector average: 46.3%) and a modest operating margin of 1.2%.
COR shows revenue growing at 9% year-over-year, with earnings growing at 3%.
COR pays a modest dividend yield of 0.9%.